---
schema_version: "secwatch.filing_event.v1"
accession: "0001035267-22-000123"
form_type: "8-K"
ticker: "ISRG"
cik: "0001035267"
company_name: "INTUITIVE SURGICAL INC"
filed_at: "2022-07-21T23:59:59+00:00"
generated_at: "2026-06-24T09:48:06.975615+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Q2 GAAP net income $308M ($0.85 EPS) down 40% YoY; revenue $1.52B up 4%

## Summary
- Worldwide da Vinci procedures grew ~14% YoY; system placements 279 (down 15%).
- Instruments & accessories revenue $895M (+12%); systems revenue $375M (-15%).
- Non-GAAP net income $415M ($1.14 per share) vs $475M ($1.30) in Q2 2021.
- Repurchased $500M of common stock in Q2; Board increased buyback authorization to $3.5B.
- Ended Q2 with $8.18B cash; cash decreased $226M due to buybacks and capex.

## SEC filing metadata
- accession: 0001035267-22-000123
- form_type: 8-K
- ticker: ISRG
- cik: 0001035267
- company_name: INTUITIVE SURGICAL INC
- filed_at: 2022-07-21T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1035267/000103526722000123/0001035267-22-000123-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1035267/000103526722000123/isrg-20220721.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001035267-22-000123
- JSON: https://secwatch.observer/filing/0001035267-22-000123.json
- Plain text: https://secwatch.observer/filing/0001035267-22-000123.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.